Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site. # etectRx ## Sitemaps - [XML Sitemap](https://etectrx.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [eBrief Expands Partnership Footprint to the Northeast with Mozaic](https://etectrx.com/ebrief-expands-partnership-footprint-to-the-northeast-with-mozaic/) - First New York Partnership Sets the Stage for Reimbursement Potential. FOR IMMEDIATE RELEASE GAINESVILLE, Florida (October 21, 2025) – etectRx™, Inc., a leading digital health sensor company, is proud to announce its eBrief™ expansion into the Northeast through a partnership with Mozaic, a chapter of the Arc New York and a premier provider of services - [etectRx Unveils Significant Enhancements to Virtual eBrief™ Community](https://etectrx.com/etectrx-unveils-significant-enhancements-to-virtual-ebrief-community/) - FOR IMMEDIATE RELEASE GAINESVILLE, Florida (October 15, 2025) – etectRx, makers of the eBrief™ Intelligent Incontinence Monitoring System, today announced significant advancements to its eBrief Community platform. Effective immediately, all resources on eBriefCommunity.com are now publicly accessible, providing caregivers with unparalleled access to industry knowledge. Additionally, eBrief partners gain exclusive access to a new, password-protected - [A Case For Change: Case 8](https://etectrx.com/a-case-for-change-case-8/) - Case 8: Embracing Ageless Adventure This week, we join the assisted living community in celebrating National Assisted Living Week (NALW), a time to honor the residents, caregivers, families, and volunteers who make these communities vibrant and nurturing places to call home. This year’s theme, "Ageless Adventure," reminds us that life’s possibilities are limitless, regardless of age - [UCLA Launches Clinical Study to Test ID-Cap® System's Technology Impact on HIV Care](https://etectrx.com/ucla-launches-clinical-study-to-test-id-cap-systems-technology-impact-on-hiv-care/) - UCLA Launches Clinical Study to Test ID-Cap® System's Technology Impact on HIV Care UCLA and The Lundquist Institute at Harbor-UCLA Medical Center, led by two Principal Investigators, Dr. Honghu Liu and Dr. Eric Daar, have launched a NIH-funded clinical study to improve HIV treatment outcomes using an innovative integrated intervention that combines ID-Cap® ingestible sensor - [A Case For Change: Case 7](https://etectrx.com/a-case-for-change-case-7/) - Case 7: A New Hub for Incontinence Resources In the care industry, finding reliable and up-to-date information can be a daunting task. With resources scattered across agencies, studies, and institutions, it’s easy to feel overwhelmed by the sheer volume of fragmented data. While there’s no shortage of information online, pinpointing insights that are relevant to your - [A Case For Change: Case 6](https://etectrx.com/a-case-for-change-case-6/) - Case 6: How eBrief Positively Impacts IDD Individuals Incontinence is often associated with aging, but it’s not a natural part of growing older—it’s often a complication stemming from health issues, physical changes, or life experiences. However, many people overlook the fact that some individuals face these challenges from birth. For those with intellectual or developmental disabilities - [New Virtual Community Launch Supports Caregivers Tackling Incontinence Challenges](https://etectrx.com/new-virtual-community-launch-supports-caregivers-tackling-incontinence-challenges/) - Changing the Script with Assistive Technology. FOR IMMEDIATE RELEASE GAINESVILLE, Florida (June 2, 2025) – Today marks the launch of etectRx’s eBrief Community, a dynamic new online community designed to support care providers navigating incontinence-related challenges. etectRx continues to Change the Script on Incontinence Care with Assistive Technology by introducing a tiered membership model offering - [Mission Health Communities Enhances Resident Care Through eBrief™ Early Adopter Program](https://etectrx.com/mission-health-communities-enhances-resident-care-through-ebrief-early-adopter-program/) - Innovative Collaboration Brings Intelligent Incontinence Monitoring to Two Kansas Care Communities FOR IMMEDIATE RELEASE GAINESVILLE, Florida (April 7, 2025) – etectRx™, Inc. (etectRx™), a leading digital health sensor company, announces its partnership with Mission Health Communities, marking a significant addition to the growing roster of eBrief™ partners. This collaboration will introduce the eBrief intelligent incontinence - [Case 5: A Case For Change](https://etectrx.com/case-5-a-case-for-change/) - Case 5: The Ripple Effect of Incontinence Management Incontinence is a well-recognized challenge in senior living, affecting not only residents' health and wellbeing but also the care teams that support them. However, its impact extends far beyond the clinical realm, influencing various aspects of a care environment. By optimizing incontinence management, senior living communities can potentially - [Black Hills Works Joins eBrief™ Early Adopter Program](https://etectrx.com/black-hills-works-joins-ebrief-early-adopter-program/) - Intelligent Incontinence Monitoring Partnership Established for Adults with Intellectual and Developmental Disabilities FOR IMMEDIATE RELEASE GAINESVILLE, Florida (March 13, 2025) – etectRx™, Inc., a leading digital health sensor company, is proud to announce its collaboration with Black Hills Works, initiating the first eBrief™ Early Adopter Program (EAP) partnership for adults with intellectual and developmental disabilities. - [Recap with ID-Cap®: Monitoring HIV Medication Adherence in University of Colorado’s QUANTI-TAF Study](https://etectrx.com/recap-with-id-cap-monitoring-hiv-medication-adherence-in-university-of-colorados-quanti-taf-study/) - In collaboration with the University of Colorado, etectRx has made significant strides in advancing medication adherence monitoring through the QUANTI-TAF study (NCT04065347). Recently published in Clinical Infectious Diseases1 and the British Journal of Clinical Pharmacology2, the QUANTI-TAF study focused on antiretroviral therapy (ART) adherence among persons with HIV (PWH) receiving daily oral tenofovir alafenamide/emtricitabine (TAF/FTC)-based ART for at least - [Case 4: A Case For Change](https://etectrx.com/case-4-a-case-for-change/) - Case 4: Streamlining Care and Reducing Clinical Risk Authored by Leah Klusch, RN, BSN, FACHCA, Executive Director, The Alliance Training Center Managing continence care in long-term care settings is a complex challenge. Incontinence treatment is among the highest expenses for providers, largely due to staffing shortages and the various regulatory and psychosocial factors involved. Addressing this - [EdenHill Communities Joins eBrief™ Early Adopter Program](https://etectrx.com/edenhill-communities-joins-ebrief-early-adopter-program/) - EdenHill Communities Partners with etectRx for Innovative Incontinence Care Solution FOR IMMEDIATE RELEASE GAINESVILLE, Florida (February 5, 2025) – etectRx™, Inc. (etectRx™), a leading digital health sensor company, is excited to announce its partnership with EdenHill Communities, marking the first eBrief™ Early Adopter Program (EAP) partnership in the State of Texas. This collaboration aims to - [Case 3: A Case For Change](https://etectrx.com/case-3-a-case-for-change/) - Case 3: Boosting Your Bottom Line As we enter a new year, senior living services face an increasingly complex landscape of reimbursement models and regulatory requirements. Terms like ACOs, MCOs, PDPM, and VBC can be overwhelming. With a growing array of payer options, senior living executives must navigate these complexities while ensuring the well-being of residents. - [Case 1: A Case For Change](https://etectrx.com/a-case-for-change/) - Case 1: Introduction November is National Bladder Awareness Month, a crucial time to highlight bladder health and the importance of managing incontinence as we age. At etectRx, we believe it is essential to initiate a transformative shift in how we address these issues. This month, we are proud to introduce "A Case for Change," an - [Case 2: A Case For Change](https://etectrx.com/case-2-a-case-for-change/) - Case 2: Why Change Is The Only Path Forward Long-term care facilities play a vital role in supporting a significant portion of our senior population. However, these facilities are currently grappling with a critical and often overlooked challenge: incontinence care. As our population ages rapidly, access to long-term care is diminishing. A report from AHCA/NCAL reveals - [Patient Response to an Ingestible Biosensor Medication Adherence System](https://etectrx.com/patient-response-to-an-ingestible-biosensor-medication-adherence-system/) - Poster by Dr. Peter Chai at Society of Behavioral Medicine - [Smart Capsules are a Promising Tool to Improve Medication Adherence in Clinical Trials](https://etectrx.com/smart-capsules-are-a-promising-tool-to-improve-medication-adherence-in-clinical-trials/) - Presentation by Aimee McCrae at the Congress on Problems of Drug Dependency Smart Capsules are a Promising Tool to Improve Medication Adherence i/n Clinical Trials - [etectRx Officially Moves into the University of Florida’s Innovation Hub](https://etectrx.com/etectrx-officially-moves-into-the-university-of-floridas-innovation-hub/) - We are proud to announce that etectRx has officially moved into the UF Innovation Hub’s ultra-modern facilities, providing our team the additional lab and office space needed to keep our work progressing in new and exciting directions. At etectRx, we are committed to advancing digital health through extensive research and innovation. Our team hangs their - [Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills](https://etectrx.com/bioequivalence-of-tenofovir-component-of-tenofovir-rilpivirine-emtricitabine-in-digital-pills/) - Bioequivalence of Tenofovir Component of Tenofovir/Rilpivirine/Emtricitabine in Digital Pills - [Formative Qualitative Response of MSM with Substance Use to Digital Pills for PrEP Adherence](https://etectrx.com/formative-qualitative-response-of-msm-with-substance-use-to-digital-pills-for-prep-adherence/) - Formative qualitative response of MSM with substance use to digital pills for PrEP adherence - [Smart Pills Are Here To Stay - An Interview With etectRx CEO, Harry Travis](https://etectrx.com/smart-pills-are-here-to-stay-an-interview-with-etectrx-ceo-harry-travis/) - The term digital pills might just sound like the latest hype from Silicon Valley - but it isn’t. The first of such devices dates back to 1957, and the technology had been developing since. The fall of healthcare startup unicorn Proteus (of which we pointed out that it’s not the tech but the company that - [Better Connections with Patients Using Data from Digital Pills](https://etectrx.com/better-connections-with-patients-using-data-from-digital-pills/) - etectRx hosted an Xtalks Webinar on December 3: “Better Connections with Patients Using Data from Digital Pills.” Susan Baumgartner, VP of Product Management and Regulatory Affairs at etectRx, started the discussion speaking about medication nonadherence, the need for digital pills and the ease of using our ID-Cap™ System. Dr. Peter Chai, a long-time collaborator of - [The Case for Digital Pill Use in Clinical Trials](https://etectrx.com/the-case-for-digital-pill-use-in-clinical-trials/) - Those who design and run clinical trials often worry about medication adherence among trial participants. Nonadherence is a significant concern in all types of clinical trials, from earlier stages of drug development (including pharmacokinetic, pharma-codynamic, dose-finding, and dose optimization studies) to late-stage pivotal trials and post-marketing studies. Medication adherence is often neglected at every phase - [Preliminary Analysis of Real-Time Therapy-Based Interventions with ID-Cap™ System Demonstrates Effectiveness of Maintaining Adherence for High-Risk Populations](https://etectrx.com/preliminary-analysis-of-real-time-therapy-based-interventions-with-id-cap-system-demonstrates-effectiveness-of-maintaining-adherence-for-high-risk-populations/) - NCT03512418- An ongoing study designed to evaluate PrEP adherence data using cognitive behavioral therapy based interventions delivered through the ID-Cap™ System in MSM (men who have sex with men) participants with substance abuse who receive oral PrEP (HIV pre-exposure prophylaxis). Early trial results from 10 pilot study subsample participants demonstrate the effectiveness of intervention messages following - [AARDEX® Group Adds etectRx to their MEMS® Adherence Hardware Ecosystem](https://etectrx.com/aardex-group-adds-etectrx-to-their-mems-adherence-hardware-ecosystem/) - The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System, and - [Formative Acceptance of Ingestible Biosensors to Measure Adherence to TB Medications](https://etectrx.com/formative-acceptance-of-ingestible-biosensors-to-measure-adherence-to-tb-medications/) - Tuberculosis (TB) represents a significant public health threat in India. Adherence to antitubercular therapy (ATT) is the key to reducing the burden of this infectious disease. Suboptimal adherence to ATT and lack of demonstrated feasibility of current strategies for monitoring ATT adherence highlights the need for alternative adherence monitoring systems. Full Abstract - [Trilogy Health Services Joins eBrief™ Early Adopter Program](https://etectrx.com/trilogy-health-services-joins-ebrief-early-adopter-program/) - Trilogy Health Services Partners with etectRx for Deployment of Novel Intelligent Incontinence Care Solution GAINESVILLE, Fla. (September 12, 2024) – etectRx™, Inc. (etectRx™), a privately held health sensor platform company, today announced an eBrief Early Adopter Program (EAP) partnership with Trilogy Health Services, a senior care communities thought leader and provider. eBrief™ is specifically engineered - [Harry Travis, CEO of etectRx, to appear on panel at NASP Annual Meeting & Expo](https://etectrx.com/harry-travis-ceo-of-etectrx-to-appear-on-panel-at-nasp-annual-meeting-expo/) - The National Association of Specialty Pharmacy (NASP) is hosting its fifth annual meeting in Washington, DC, September 18-20, 2o17. etectRx™ is proud that Harry Travis will be speaking as part of a panel during the session titled "Using Digital Technologies, Robotics, and AI to Improve Medication Adherence". If you are attending the NASP Annual Meeting & - [NW Arkansas Technology Summit to feature presentation from Harry Travis](https://etectrx.com/nw-arkansas-technology-summit-to-feature-presentation-from-harry-travis/) - The theme of the 2017 Northwest Arkansas Technology Summit is Connected Devices, Connected World, which translates into the work that etectRx™ is championing in the medication adherence field. Travis will speak in a session titled "Can Digital Technologies Solve our $300 billion Medication Adherence Problem?" and will comment on the ever-growing connection between healthcare and technology - [etectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System](https://etectrx.com/etectrx-inc-announces-issuance-of-u-s-patent-for-ingestible-medication-compliance-system/) - GAINESVILLE, Fla. (Sept. 7, 2017) – etectRx™, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has issued U.S. Patent 9,743,880 for an “Electronic Medication Compliance Monitoring System and Associated Methods.” The patent covers an ingestible electronic tag system and a method for monitoring a patient’s compliance - [UF’s Newly Expanded Innovation Hub Welcomes etectRx](https://etectrx.com/ufs-newly-expanded-innovation-hub-welcomes-etectrx/) - etectRx™ is committed to advancing digital health through extensive research and innovation. When considering a location for the new office, it was crucial that the facility not only meet basic needs but also support and promote the company’s existing mission. With ultra modern facilities and cutting-edge technology, The University of Florida’s Innovation Hub was the perfect match. Since - [Guardian angel or watchdog? Pills of capecitabine contain sensors](https://etectrx.com/guardian-angel-or-watchdog-pills-of-capecitabine-contain-sensors/) - CEO of etectRx, Harry Travis, spoke with MDedge about the future of digital medicine and how our state-of-the-art ID-Cap system can impact the medical industry. Read more at https://www.mdedge.com/hematology-oncology/article/193696/patient-survivor-care/guardian-angel-or-watchdog-pills - [Digital Pills May Be on the Horizon in Cancer Care](https://etectrx.com/digital-pills-may-be-on-the-horizon-in-cancer-care/) - CEO of etectRx, Harry Travis, spoke with Oncology Live about digital pills, like the ID-Capsule, as a possibility for improving cancer care. Read more at https://www.onclive.com/publications/Oncology-live/2019/vol-20-no-5/digital-pills-may-be-on-the-horizon-in-cancer-care?p=1 - [etectRx's Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study](https://etectrx.com/etectrxs-innovative-id-cap-system-selected-to-track-medication-ingestion-in-hiv-prevention-study/) - Digital Medicine System has the potential to provide clinicians with a new tool to track and manage adherence for HIV prevention therapy GAINESVILLE, Fla. (March 4, 2019) – etectRx™, a privately held digital health company, is pleased to announce that its ID-Cap™ System, featuring state-of-the-art ingestion event monitoring technology, has been selected for a new - [etectRx and Qualicaps Extend Strategic Relationship to Develop ID-Cap Technologies and Digital Pharma Market Opportunities](https://etectrx.com/etectrx-and-qualicaps-extend-strategic-relationship-to-develop-id-cap-technologies-and-digital-pharma-market-opportunities/) - Qualicaps® to Display ID-Capsule™ Technology at INTERPHEX Week Japan GAINESVILLE, Fla. (June 6, 2019) – etectRx™ and Qualicaps® have extended their existing collaborative relationship to further develop the manufacturing and assembly processes for ID-Capsules and the ID-Cap™ System. In addition, the two companies will work collaboratively to explore markets for etectRx’s proprietary technology and expand - [etectRx, Inc. Announces Issuance of Additional U.S. Patents for Ingestible Medication Adherence System](https://etectrx.com/etectrx-inc-announces-issuance-of-additional-u-s-patents-for-ingestible-medication-adherence-system/) - GAINESVILLE, Fla. (June 10, 2019) – etectRx™ Inc., an early-stage digital health company, today announced that the United States Patent and Trademark Office has issued U.S. Patent 10,292,642 for an “Electronic Medication Compliance Monitoring System and Associated Methods.” The patent covers an ingestible electronic system and methods for recording and tracking a patient’s adherence to - [Technology You Ingest: Interview with Harry Travis](https://etectrx.com/technology-you-ingest-interview-with-harry-travis/) - Harry Travis, president & CEO of etectRx, interviewed with the Orlando Entrepreneurs podcast to share the company story. Listen here at https://www.orlandoentrepreneurs.org/technology-you-ingest-interview-with-harry-travis/ - [etectRx Announces U.S. FDA Clearance of Novel Ingestible Event Marker](https://etectrx.com/etectrx-announces-u-s-fda-clearance-of-novel-ingestible-event-marker/) - ID-Cap System Uses Advanced Wireless Technology to Reliably Track Ingestion Events GAINESVILLE, Fla. (December 9, 2019) – etectRx®, Inc. (etectRx), a privately-held digital health company, today announced U.S. Food and Drug Administration (FDA) clearance of its breakthrough patented ingestible event marker, the ID-Cap® System. The ID-Cap System is the first and only ingestible event marker - [Future Proof Pharmacy with Harry Travis - Pharmacy Podcast Nation](https://etectrx.com/future-proof-pharmacy-with-harry-travis-pharmacy-podcast-nation/) - The original host of the Specialty Pharmacy Podcast and a frequent guest on the Pharmacy Podcast Network, Harry Travis, etectRx President & CEO, joins Todd Eury on FutureDose.tech discussing how to "Future Proof Pharmacy". Listen here: https://omny.fm/shows/pharmacy-podcast-network/future-proof-pharmacy-with-harry-travis-ppn-episod - [Breakthrough ID-Cap System from etectRx™ Selected to Measure Adherence to HIV Treatment in New University of Colorado Study](https://etectrx.com/breakthrough-id-cap-system-from-etectrx-selected-to-measure-adherence-to-hiv-treatment-in-new-university-of-colorado-study/) - Announcement coincides with the issuance of two new U.S. Patents GAINESVILLE, Fla. (January 12, 2020) – etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication. This collaborative - [Rx Radio: Embedding Sensors in Capsules with CEO of etectRx](https://etectrx.com/rx-radio-embedding-sensors-in-capsules-with-ceo-of-etectrx/) - It’s 2020 and embedding sensors in capsules is actually here. One company has recently received a breakthrough FDA clearance for their patented ingestible event marker, called the ID-Cap® System. That company is etectRx, and on this episode, we interview their CEO and President, Harry Travis. Harry walks us through how the technology works, challenges of - [Webcast: Can a Digital Pill Improve Clinical Trials in this Pandemic and Beyond?](https://etectrx.com/webcast-can-a-digital-pill-improve-clinical-trials-in-this-pandemic-and-beyond/) - Strategies to Enable Remote Ingestion Monitoring, Patient Retention, and Quality Data COVID-19 has resulted in suspensions of an unprecedented number of clinical trials. Remote trials can be enabled with digital technologies that provide assurance with real-time adherence monitoring and high-quality, real-world medication-taking data. Learn how these technologies have been used in trials to date and - [etectRx Completes HIV-Prevention Study Using ID-Cap System to Track Medication Ingestion](https://etectrx.com/etectrx-completes-hiv-prevention-study-using-id-cap-system-to-track-medication-ingestion/) - Digital Medicine System Provides Clinicians with an Accurate Tool to Manage Adherence etectRx™, a privately-held digital health company, is pleased to announced the successful completion of a clinical study using the ID-Cap™ System to track and report medication adherence in HIV prevention. The researchers utilized etectRx’s ID-Cap System to examine medication adherence patterns in 16 - [Pharmacy Podcast Network: Discussion of Digital Pills](https://etectrx.com/pharmacy-podcast-network-discussion-of-digital-pills/) - Harry Travis and Valerie Sullivan from etectRx join the Pharmacy Podcast Network to discuss how digital pills can improve clinical trials. Listen in here: https://bit.ly/2VblJbU - [Webcast: How Digital Pills Can Improve Clinical Trials](https://etectrx.com/webcast-how-digital-pills-can-improve-clinical-trials/) - In this video webcast, etectRx’s own Dr. Susan Baumgartner, Vice President of Product Management & Regulatory Affairs, and Dr. Peter Chai, Emergency Medicine, Medical Toxicology at Brigham and Women’s Hospital, discuss how digital pills can improve clinical trials and present how the ID-Cap™ System has been used in trials to date for real-time medication adherence - [etectRx Launches First-Ever Virtual, Multi-Pill Clinical Trial Using Next-Generation ID-Tag](https://etectrx.com/etectrx-launches-first-ever-virtual-multi-pill-clinical-trial-using-next-generation-id-tag/) - Late last week, we launched the first-ever virtual, multi-pill clinical trial to evaluate our ID-Cap™ System’s next-generation ingestible sensor, the ID-Tag 1.6. The ID-Cap System will allow our clinicians to utilize telehealth to remotely monitor patients and track ingestions in real time. This approximate one-month study will include 150 ingestions, with remote monitoring throughout, and - [etectRx™ Announces New CEO](https://etectrx.com/etectrx-announces-new-ceo/) - Pharma Executive Brought in to Drive Digital Pill Use Cases GAINESVILLE, Fla. (August 20, 2020) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of pharma veteran Valerie Sullivan as its next president and CEO. In late 2019, the company received FDA clearance for its novel ingestible event marker, the ID-Cap™ System. etectRx is in dialogue with pharma companies to help drive commercialization for its novel technology. Sullivan, who - [etectRx™ Announces Clinical Study Aimed at Improving Medication Adherence](https://etectrx.com/etectrx-announces-clinical-study-aimed-at-improving-medication-adherence/) - ID-Cap™ System Will Allow Cliniciansto Remotely Track Ingestion Events and Provide Feedback to Patients GAINESVILLE, Fla. (September 10, 2020) – Digital health company etectRx™, Inc. (etectRx™), today announced that its FDA-cleared ingestible event marker, the ID-Cap™ System, will be utilized in a clinical study of 60 patients to develop programs aimed to improve medication adherence - [etectRx Strengthens Intellectual Property Portfolio with 15th Issued Patent Supporting Digital Pill Innovation](https://etectrx.com/etectrx-strengthens-intellectual-property-portfolio-with-15th-issued-patent-supporting-digital-pill-innovation/) - GAINESVILLE, Fla. (October 7, 2020) – etectRx, Inc. recently announced that the United States Patent and Trademark Office has issued U.S. Patent 10,765,360 for an “Electronic medication compliance monitoring system and associated methods.” The patent supports the company’s existing intellectual property for its digital pill platform technology and methods for recording and tracking a patient’s adherence - [Pharma Pro Brings Experience to Digital Pill Company - Orlando Medical News](https://etectrx.com/pharma-pro-brings-experience-to-digital-pill-company-orlando-medical-news/) - CEO Valerie Sullivan spoke with Orlando Medical News about how her pharma experience will benefit etectRx as it continues to innovate medication adherence. Full Story - [The ID-Cap™ System: A Patient's Perspective](https://etectrx.com/the-id-cap-system-a-patients-perspective/) - "I felt confident that the digital pill was safe, I knew it was effective. I didn't have to worry about whether I could remember taking it and truly, it changed the way I approached my own health" - Court, 31 You asked what our patients think of the etectRx ID-Cap System and we answered. etectRx's - [Webinar 12/3: Better Connections with Patients Using Data from Digital Pills](https://etectrx.com/webinar-12-3-better-connections-with-patients-using-data-from-digital-pills/) - Digital pills offer the potential to help researchers truly understand connections between medication adherence and patient outcomes. The use of digital pills in clinical trials can help researchers have more confidence in their data, and can provide data that links dose to time of ingestion, dose to medication levels, as well as real-time notifications of - [Design and Delivery of Real‑Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre‑exposure Prophylaxis via an Ingestible Electronic Sensor](https://etectrx.com/design-and-delivery-of-real‑time-adherence-data-to-men-who-have-sex-with-men-using-antiretroviral-pre‑exposure-prophylaxis-via-an-ingestible-electronic-sensor/) - Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a paper drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants. Dr. Chai’s paper was accepted for publication and recently published in peer-reviewed medical journal AIDS and Behavior. View - [Long-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings](https://etectrx.com/long-term-stability-of-the-electronic-sensor-component-of-a-digital-pill-system-in-real-world-storage-settings/) - Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants. Dr. Chai’s research report was recently published in the Journal of Pharmacy Technology by SAGE. View Abstract - [etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics](https://etectrx.com/etectrx-announces-agreement-to-advance-digital-sensors-for-medication-adherence-in-combination-with-prescription-digital-therapeutics/) - GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The collaboration is the first of its kind to - [Failure Risk in Clinical Trials? An Easy-to-Swallow Solution](https://etectrx.com/failure-risk-in-clinical-trials-an-easy-to-swallow-solution/) - Our CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote patient monitoring and telehealth, our technology is a safe, effective and FDA cleared solution. Read Full Article - [Digital Pill Company etectRx Selects Biotech Leader as VP of Product Management](https://etectrx.com/digital-pill-company-etectrx-selects-biotech-leader-as-vp-of-product-management/) - GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx digital pill ID-Cap™ System. Standley’s onboarding aligns with recent etectRx partnerships with other digital health providers working toward providing solutions - [etectRx Targets Mental Health Field In Partnership With Local Health Pharmacy](https://etectrx.com/etectrx-targets-mental-health-field-in-partnership-with-local-health-pharmacy/) - GAINESVILLE, Fla. (February 26, 2021) – Digital health company, etectRx, Inc., announced a signed letter of intent for a novel partnership with Local Health, Inc., a subsidiary of OneroRx, a leader in operating telepharmacies and community retail pharmacies. The partnership is structured to evaluate patient acceptability of the etectRx FDA-cleared digital pill ID-Cap™ System. Local - [Digital Pill Study Shows Significant Impact on Hepatitis C Treatment Adherence and Efficacy](https://etectrx.com/digital-pill-study-shows-significant-impact-on-hepatitis-c-treatment-adherence-and-efficacy/) - A study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine program (DMP) on medication adherence (Proteus Digital Health) in a population at risk for nonadherence. The study was a prospective, single-arm, open-label study at 18 US academic and community clinics. All - [High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic](https://etectrx.com/high-patient-engagement-with-the-id-cap-system-on-98-0-of-use-days-in-a-clinical-study-during-the-covid-19-pandemic-2/) - COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical - [The ID-Cap™ System: A Physician's Perspective](https://etectrx.com/the-id-cap-system-a-physicians-perspective/) - “The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite easily and be engaged with the system.” – Dr. Jose Castillo-Mancilla, MD, Physician and Clinical Researcher. In this video, Dr. Jose Castillo-Mancilla speaks about the importance of the connection between - [A Brief Training Program to Support the Use of a Digital Pill System for Medication Adherence: Pilot Descriptive Study](https://etectrx.com/a-brief-training-program-to-support-the-use-of-a-digital-pill-system-for-medication-adherence-pilot-descriptive-study/) - In partnership with our collaborators at academic medical centers in the United States, etectRx has created a simple and streamlined training program for our FDA-cleared ID-Cap System that positions patients for success with our technology and their therapy. The training has been effectively and efficiently delivered by clinical research teams as they have successfully used - [etectRx "It Already Does That"](https://etectrx.com/etectrx-it-already-does-that/) - Inspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It Already Does That” highlighting our FDA cleared ID-Cap™ System. We are passionate about the need to empower patients and expand the connection a person has to their own healthcare, while - [etectRx Announces Launch of MyTPill Study to Address Medication Adherence Among HIV+ Prescription Opioid Users](https://etectrx.com/etectrx-announces-launch-of-mytpill-study-to-address-medication-adherence-among-hiv-prescription-opioid-users/) - GAINESVILLE, Fla. & BOSTON, Mass. (May 4, 2021) – Digital health company, etectRx, Inc., today announced the launch of a study to monitor antiretroviral therapy adherence among prescription opioid users living with HIV. The study, dubbed “MyTPill,” will assess patient adherence using two electronic adherence tracking technologies: the ID-Cap™ System from etectRx and an electronic - [WHITEPAPER: The Extraordinary Problem of Medication Nonadherence in Oncology Patients And How Digital Pills Can Make a Difference](https://etectrx.com/whitepaper-the-extraordinary-problem-of-medication-nonadherence-in-oncology-patients-and-how-digital-pills-can-make-a-difference/) - Cancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated outside the hospital setting. Yet many patients fail to take their medication consistently, despite the potentially dire consequences of not adhering to the prescribed oncology treatment plan. Nonadherence or suboptimal - [etectRx Announces Eric Buffkin as New CEO](https://etectrx.com/etectrx-announces-eric-buffkin-as-new-ceo/) - Company Founder Takes the Helm of etectRx, a Digital Health Company GAINESVILLE, Fla. (August 2, 2021) – etectRx™, Inc. (etectRx™), a privately held digital health company, today announced the appointment of Eric Buffkin as its next president and CEO. etectRx received FDA clearance for its novel ingestible event marker, the ID-Cap™ System in late 2019, - [Development of a Digital Pill and Respondent Behavioral Intervention (PrEPSteps) for HIV Pre-exposure Prophylaxis Adherence Among Stimulant Using Men Who Have Sex With Men](https://etectrx.com/development-of-a-digital-pill-and-respondent-behavioral-intervention-prepsteps-for-hiv-pre-exposure-prophylaxis-adherence-among-stimulant-using-men-who-have-sex-with-men/) - Our ID-Cap™ System was recently utilized in a clinical study in Boston, MA resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the use of a digital pill system (DPS) for real-time, objective measurement of ingestions among study participants. Dr. Chai’s research report was recently published in Translational Behavioral Medicine - [High Patient Engagement with the ID-Cap™ System on 98.0% of Use-Days in a Clinical Study During the COVID-19 Pandemic](https://etectrx.com/high-patient-engagement-with-the-id-cap-system-on-98-0-of-use-days-in-a-clinical-study-during-the-covid-19-pandemic/) - COVID-19 caused many interruptions in clinical trials. After a brief pause in external clinical research, clinical studies involving use of the FDA-cleared ID-Cap System from etectRx resumed in July of 2020. etectRx sought to understand if patients were engaged with our digital pill system when used to track and report their medication-taking in a clinical - [Remote Therapy Monitoring Billing Guide](https://etectrx.com/remote-therapy-monitoring-billing-guide/) - In 2022 the Centers for Medicare and Medicaid Services (CMS) expanded its digital health coverage and began reimbursing providers for remote therapy monitoring (RTM). RTM differs from existing Remote Patient Monitoring (RPM) in that it monitors therapeutic data, such as medication adherence. RPM measures physiologic data, such as blood pressure and heart rate. Unlike the - [Leading Digital Pill Solution Surpasses 10,000 Ingestions](https://etectrx.com/leading-digital-pill-solution-surpasses-10000-ingestions/) - etectRx™, Inc. (etectRx™), the standard in FDA-cleared digital medication adherence, today announced that its digital pill, the ID-Cap System has surpassed 10,000 ingestions, a significant milestone for the company with a reputation for demonstrating strong results and providing data to accurately track patients’ adherence to their oral medications. Continue Reading - [ID-Cap™ System Powers Historic HIV Digital Pill Study](https://etectrx.com/id-cap-system-powers-historic-hiv-digital-pill-study/) - etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in Adults living with HIV (QUANTI-TAF) study evaluated drug concentrations in dried blood spots (DBS), in tandem with medication adherence measured by the ID-Cap™ System. The ID-Cap™ System’s remote patient monitoring - [Global Growth: University of Cape Town Announces ID-Cap™ System Acceptability Study](https://etectrx.com/global-growth-university-of-cape-town-announces-id-cap-system-acceptability-study/) - University of Cape Town announces ID-Cap™ System acceptability study in South Africa. Mass General Brigham in collaboration with University of Cape Town is conducting a new research study to assess the feasibility and acceptability of a digital pill system for monitoring medication adherence in individuals with HIV-TB co-infection in South Africa. Adherence to medication regimens - [ID Cap™ System Evolution: Introducing the Wrist-Worn Reader](https://etectrx.com/id-cap-system-evolution-introducing-the-wrist-worn-reader/) - The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication non-adherence. Medication nonadherence is a widespread problem, resulting in significant healthcare costs and challenges for individuals managing chronic conditions. In particular, adherence is crucial in the context of HIV prevention, where - [etectRx and The Village at Gainesville Announce Intelligent Incontinence Care Collaboration](https://etectrx.com/etectrx-and-the-village-at-gainesville-announce-intelligent-incontinence-care-collaboration/) - Partnership Marks First Industry Use of Novel Disposable eBrief GAINESVILLE, Fla. (November 13, 2023) – etectRx™, Inc. (etectRx™), a privately held silicon-enabled digital health sensor platform company, today announced a first-of-its-kind pilot project with The Village at Gainesville, a vibrant retirement community. The pilot represents the debut application of eBrief, etectRx’s patented intelligent incontinence monitoring system. - [ALOHA! Adherence: ID-Cap™ Clinical Trial Research Presented at the 2024 Hawaii International Conference on System Sciences (HICSS)](https://etectrx.com/aloha-adherence-id-cap-clinical-trial-research-presented-at-the-2024-hawaii-international-conference-on-system-sciences-hicss/) - The ID-Cap™ System embarks on a promising journey in 2024, receiving continued praise from clinical trials. Researchers from Brigham and Women's Hospital and Ohio State University welcomed the new year in sunny Honolulu to present valuable clinical trial data at the Hawaii International Conference on System Sciences (HICSS) 2024. The momentum of medication adherence carried - [etectRx Welcomes Scott Kozimor as Vice President of Sales, Driving Innovation in Long-Term Care Technology](https://etectrx.com/etectrx-welcomes-scott-kozimor-as-vice-president-of-sales-driving-innovation-in-long-term-care-technology/) - GAINESVILLE, FL. (February 15, 2024) – etectRx, a leading innovator in digital health sensor solutions, proudly announces the appointment of Scott Kozimor as Vice President of Sales. With an illustrious career spanning over two decades in long-term care and a profound understanding of technology solutions, Scott will play a pivotal role in shaping the trajectory ## Pages - [Home](https://etectrx.com/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Terms of Services](https://etectrx.com/terms-of-services/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Privacy Policy Web](https://etectrx.com/privacy-policy-web/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [eBurst™](https://etectrx.com/eburst/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [About Us](https://etectrx.com/about-us/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Privacy Policy](https://etectrx.com/privacy-policy/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [eBrief™ System](https://etectrx.com/ebrief/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [ViVE 2023 Conference Resources](https://etectrx.com/vive2023resources/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Videos](https://etectrx.com/media/videos/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [ViVE 2023 Resources](https://etectrx.com/vive2023/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Blog](https://etectrx.com/media/blog/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Events](https://etectrx.com/media/events/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Newsroom](https://etectrx.com/media/newsroom/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Terms of Use](https://etectrx.com/terms-of-use/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Clinicals](https://etectrx.com/media/clinicals/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [News](https://etectrx.com/media/news/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Media](https://etectrx.com/media/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Clinical Trials](https://etectrx.com/clinical-trials/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [eBrief Partners](https://etectrx.com/pilot-partnership-opportunities/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. ## Team - [Rich Kruzynski, RPh](https://etectrx.com/team/rich-kruzynski-rph/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Edward Hensley](https://etectrx.com/team/edward-hensley/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Jeff Spafford](https://etectrx.com/team/jeff-spafford/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Dennis Jakubowicz](https://etectrx.com/team/dennis-jakubowicz/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Dr. Gerald Klein, MD](https://etectrx.com/team/dr-gerald-klein-md/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Dr. Peter C. Johnson, MD](https://etectrx.com/team/dr-peter-c-johnson-md/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Neil R. Euliano II, PhD](https://etectrx.com/team/neil-r-euliano-ii-phd/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Scott Kozimor](https://etectrx.com/team/scott-kozimor/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Adam Standley](https://etectrx.com/team/adam-standley/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [Tony Christopher Carnes, PhD](https://etectrx.com/team/tony-christopher-carnes-phd/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. - [D. Eric Buffkin Jr.](https://etectrx.com/team/d-eric-buffkin-jr/) - etectRx's FDA-cleared ID-Cap™ System addresses the issue with medication adherence, allowing pharma to innovate with confidence and accelerate patient outcomes. ## Categories - [Press Releases](https://etectrx.com/category/press-releases/) - [Clinicals](https://etectrx.com/category/clinicals/) - [Blog](https://etectrx.com/category/blog/) - [Newsroom](https://etectrx.com/category/newsroom/) - [Events](https://etectrx.com/category/events/) ## Team Group - [Board of Directors](https://etectrx.com/team_group/board-of-directors/) - [Management](https://etectrx.com/team_group/management/) - [Advisors](https://etectrx.com/team_group/advisors/)